Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
06 June 2019 | Story Valentino Ndaba | Photo Rian Horn
Solar Panels at UFS Qwaqwa Campus
Revolutionising electricity with sun power: Solar panels at the Qwaqwa Campus.

Over the past few years the University of the Free State (UFS) has been planting panels, now the time has come to reap. Solar farms produced a return on investment in the form of R1.4 million in savings as a result of photovoltaics (PV) between January and March 2019. Nicolaas Esterhuysen, an electrical engineer at the Department of University Estates also reported a 2.34% decline in electricity usage between 2013 and 2018. 

Solar panels are the future 

According to Esterhuysen, the solution to a power crisis lies in “either becoming more energy efficient or generating our own at a cheaper cost”. All campuses have managed to save a total of R5.4 million in 2018 through producing our own power (solar PV) and actively managing the instantaneous load demand with building management system (BMS) software.

Overall, ground-mounted PV installations at all campuses contribute 2609 kilowattpeak (kWp) under standard conditions. The Bloemfontein Campus accounts for 979kWp of that amount while the South Campus generates 762kWp, with the Qwaqwa Campus producing 748kWp, and the Paradys experimental farm bringing in 120kWp to the grand total (to be commissioned June 2019).

Rooftop PVs generate electricity through the 80kWp Muller Potgieter Building, the 255kWp Bloemfontein Campus computer lab, the 35kWp Qwaqwa Campus computer lab, 135kWp Qwaqwa Campus Mandela Hall, and 416kWp Thakaneng Bridge panels. This is a total of 921kWp. 

Winter is coming with tariff terrors 

A 15.63% electricity tariff increase is projected this year in light of the annual winter adjustments commissioned by Eskom and Centlec. To gear up for the associated spike in power use over this season, University Estates advises the Kovsie community to use energy efficiently. “Think twice before switching on the heating and make sure to switch it off when you leave the office,” advises Esterhuysen.

In addition to generating electricity, saving initiatives such as implementing light-emitting diode (LED) lighting with motion sensors and actively managing demand at peak times have been implemented.

What’s next?

The next step is to rethink dated mechanical installations that are used to heat some of our older buildings. Replacing similar installations across all of the campuses are some of the ways the university intends to escalate energy efficient in future. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept